dihydroxyphenylalanine and 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane

dihydroxyphenylalanine has been researched along with 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jennings, D; Marek, K; Seibyl, J1
Eshuis, SA; Jager, PL; Jonkman, S; Leenders, KL; Maguire, RP1
Dierckx, RA; Eshuis, SA; Jager, PL; Jonkman, S; Leenders, KL; Maguire, RP1
Remy, P1
Bjorklund, A; Brooks, DJ; Lindvall, O; Oertel, WH; Piccini, P; Pogarell, O; Politis, M; Quinn, NP; Wu, K1

Reviews

2 review(s) available for dihydroxyphenylalanine and 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane

ArticleYear
Do dopamine agonists or levodopa modify Parkinson's disease progression?
    European journal of neurology, 2002, Volume: 9 Suppl 3

    Topics: Animals; Antiparkinson Agents; Benzothiazoles; Carrier Proteins; Dihydroxyphenylalanine; Disease Progression; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Humans; Indoles; Iodine Radioisotopes; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Neostriatum; Nerve Tissue Proteins; Parkinson Disease; Pramipexole; Radiopharmaceuticals; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Tropanes

2002
[Functional imaging: role for the diagnosis and therapeutic evaluation of Parkinson's disease].
    Revue neurologique, 2010, Volume: 166, Issue:10

    Topics: Antiparkinson Agents; Brain Chemistry; Diagnosis, Differential; Dihydroxyphenylalanine; Dopamine Agents; Glucose; Humans; Nortropanes; Parkinson Disease; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon

2010

Other Studies

3 other study(ies) available for dihydroxyphenylalanine and 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane

ArticleYear
Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease.
    European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:2

    Topics: Adult; Aged; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Image Processing, Computer-Assisted; Male; Membrane Transport Proteins; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon; Tropanes

2006
Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson's disease and healthy controls.
    European journal of nuclear medicine and molecular imaging, 2009, Volume: 36, Issue:3

    Topics: Adult; Aged; Brain; Case-Control Studies; Dihydroxyphenylalanine; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sex Characteristics; Tomography, Emission-Computed, Single-Photon; Tropanes

2009
Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio.
    Movement disorders : official journal of the Movement Disorder Society, 2011, Volume: 26, Issue:11

    Topics: Brain Mapping; Brain Tissue Transplantation; Corpus Striatum; Dihydroxyphenylalanine; Dopamine Plasma Membrane Transport Proteins; Dyskinesias; Functional Laterality; Humans; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Serotonin Plasma Membrane Transport Proteins; Time Factors; Tomography, Emission-Computed, Single-Photon; Tropanes

2011